SPECIAL TOPIC
Tetrasubstituted Allene Ethers; Synthesis and Use in Nazarov Reactions
789
1H NMR (300 MHz, CDCl3): d = 6.45 (m, 1 H, HC=C=C), 4.77 (s,
2 H, OCH2O), 3.41 (s, 3 H, OCH3), 2.02 (m, 2 H, CH2), 1.79 (d, 3
H, J = 2.1 Hz, CH3), 1.46–1.23 (m, 8 H, CH2), 0.90–0.85 (m, 3 H,
CH3).
with aq NaHCO3 and Et2O. The aq phase was extracted with Et2O,
the combined organic extracts were dried (MgSO4), and the solvent
was removed in vacuo. Column chromatography (silica gel; 5%
EtOAc–hexane) gave 23a as a ca. 1:1 mixture of E and Z isomers.
13C NMR (75 MHz, CDCl3): d = 189.0, 116.7, 116.0, 94.9, 56.1,
35.9, 32.0, 29.2, 27.6, 22.8, 21.6, 14.3.
Yield: 118 mg (0.35 mmol; 69%); yellow oil.
E + Z-23a
MS (EI): m/z (%) = 68 (16), 81 (14), 128 (100), 142 (12), 198 (1).
HRMS: m/z calcd for C12H22O2 [M+]: 198.1620; found: 198.1615.
IR (film): 2990, 1695, 1630 cm–1.
1H NMR (300 MHz, CDCl3): d = 6.99 (d, 4 H, J = 8.7 Hz, ArH),
6.81 (d, 4 H, J = 8.7 Hz, ArH), 4.10 (s, 1 H, CH), 4.06 (s, 1 H, CH),
3.78 (s, 3 H, OCH3), 3.77 (s, 3 H, OCH), 2.90 (m, 2 H, CH2), 2.68
(m, 2 H, CH2), 2.29 (m, 2 H, CH2), 2.28 (s, 3 H, CH3), 2.27 (s, 3 H,
CH3), 1.93 (m, 2 H, CH2), 1.74 (s, 3 H, CH3), 1.58 (s, 3 H, CH3),
1.28–1.06 (m, 16 H, CH2), 1.05 (m, 3 H, CH3), 1.03 (m, 3 H, CH3),
0.84 (m, 3 H, CH3), 0.82 (m, 3 H, CH3).
2-Hydroxy-3-methyl-5-(1-methylheptylidene)-4-phenylcyclo-
pent-2-enone (18a)
To a solution of allene 16a (200 mg, 1.01 mmol) in THF (5 mL) was
added BuLi (0.45 mL; 1.21 mmol; 2.7 M solution in hexane) at
–78 °C. After stirring for 1 h, morpholino enamide 17 (280 mg, 1.21
mmol) in THF (3 mL) was added via cannula. After stirring for 2 h,
the reaction was transferred by cannula in to a solution of FeCl3
(204 mg, (2.00 mmol) in Et2O (10 mL). The reaction mixture was
diluted with aq NaHCO3 and Et2O. The aq phase was extracted with
Et2O, the combined organic extracts were dried (MgSO4), and the
solvent was removed in vacuo. Column chromatography (silica gel;
5% EtOAc–hexane) gave 18a as a ca. 1:2 mixture of E and Z iso-
mers.
MS (EI): m/z (%) = 69 (37), 91 (26), 101 (13), 115 (20), 135 (21),
147 (47), 175 (100), 204 (49), 270 (32), 340 (59).
HRMS: m/z calcd for C23H32O2 [M+]: 340.2402; found: 340.2416.
2-Amino-3-methyl-5-(1-methylheptylidene)-4-phenylcyclo-
pent-2-enone (20a)
To a solution of allene 16a (200 mg, 1.01 mmol) in THF (5 mL) was
added BuLi (0.45 mL; 1.21 mmol; 2.7 M solution in hexane)
–78 °C. After stirring for 1 h, a-methylcinnamonitrile (19) (144 mg,
0.14 mmol) was added via cannula. The reaction mixture was
warmed to –40 °C and stirred for 1 h. The mixture was then trans-
ferred by cannula into a solution of FeCl3 (204 mg, 2.00 mmol) in
Et2O (10 mL). The reaction mixture was diluted with aq NaHCO3
and Et2O. The aq phase was extracted with Et2O, the combined or-
ganic extracts dried (MgSO4), and the solvent was removed in vac-
uo. Column chromatography (silica gel; 5% EtOAc–hexane) gave
E-20a and Z-20a (ca. 1:2).
Yield: 216 mg (0.73 mmol; 72%); yellow oil.
Compound Z-18a
IR (film): 3250, 1690, 1640, 1400 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.31–7.06 (m, 5 H, ArH), 5.79 (s,
1 H, OH), 4.09 (s, 1 H, CH), 2.95–2.70 (m, 2 H, CH2), 1.71 (d, 3 H,
J = 1.2 Hz, CH3), 1.58 (s, 3 H, CH3), 1.43–1.25 (m, 8 H, CH2), 0.91–
0.85 (m, 3 H, CH3).
13C NMR (75 MHz, CDCl3): d = 190.2, 163.3, 152.9, 150.5, 139.8,
138.4, 131.7, 128.2 (2 C), 127.1 (2 C), 50.2, 37.3, 31.8, 29.5, 26.8,
22.7, 18.5, 14.3, 11.6.
Yield: 195 mg (0.65 mmol; 68% combined yield); orange oils.
MS (EI): m/z (%) = 67 (15), 77 (15), 185 (45), 214 (6), 228 (19), 242
(37), 298 (72).
HRMS: m/z [M+] calcd for C20H26O2: 298.1933; found: 298.1952.
Compound E-20a
IR (film): 3490, 3380, 1650, 1560 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.42–7.06 (m, 5 H, ArH), 4.11 (s,
1 H, CH), 2.28 (s, 3 H, CH3), 1.94–1.89 (m, 2 H, CH2), 1.63 (s, 3 H,
CH3), 1.28–0.87 (m, 8 H, CH2), 0.82 (m, 3 H, CH3).
13C NMR (75 MHz, CDCl3): d = 191.0, 151.2, 142.2, 142.1, 134.6,
133.0, 128.5, 127.9 (2 C), 126.4 (2 C), 51.5, 33.3, 31.8, 29.3, 28.4,
22.6, 21.6, 14.1, 12.3.
Compound E-18a
IR (film): 3300, 1680, 1400 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.29–7.08 (m, 5 H, ArH), 5.74 (s,
1 H, OH), 4.19 (s, 1 H, CH), 2.29 (s, 3 H, CH3), 1.98–1.86 (m, 2 H,
CH2), 1.70 (d, 3 H, J = 0.9 Hz, CH3), 1.28–0.93 (m, 8 H, CH2), 0.84
(t, 3 H, J = 3.3 Hz, CH3).
13C NMR (75 MHz, CDCl3): d = 190.3, 168.2, 150.4, 141.2, 136.6,
131.9, 128.5, 128.0 (2 C), 126.8 (2 C), 50.4, 33.8, 31.9, 29.4, 28.6,
22.8, 21.7, 14.3, 11.7.
MS: m/z (%) = 185 (42), 241 (18), 255 (16), 297 (89).
HRMS: m/z calcd for C20H27NO [M+]: 297.2093; found: 297.2079.
Compound Z-20a
IR (film): 3490, 3380, 1650, 1560 cm–1.
MS (EI): m/z (%) = 105 (65), 115 (29), 129 (26), 149 (21), 167 (13),
185 (54), 209 (14), 228 (100), 241 (28), 298 (69).
HRMS: m/z calcd for C20H26O2 [M+]: 298.1933; found: 298.1948.
1H NMR (300 MHz, CDCl3): d = 7.28–7.01 (m, 5 H, ArH), 4.07 (s,
1 H, CH), 2.95–2.70 (m, 2 H, CH2), 1.63 (d, 3 H, J = 1.2 Hz, CH3),
1.56 (s, 3 H, CH3), 1.50–1.27 (m, 8 H, CH2), 0.87 (m, 3 H, CH3).
13C NMR (75 MHz, CDCl3): d = 191.9, 150.3, 142.4, 142.3, 134.6,
132.8, 129.7, 128.4 (2 C), 126.5 (2 C), 51.2, 37.3, 31.6, 29.3, 26.6,
22.4, 14.7, 14.1, 12.3.
2-Ethyl-4-(4-methoxyphenyl)-3-methyl-5-(1-methylheptyl-
idene)cyclopent-2-enone (23a)
To a solution of allene 16a (200 mg; 1.01 mmol) in THF (5 mL) was
added BuLi (0.45 mL; 1.21 mmol; 2.7 M solution in hexane) at
–78 °C. After stirring for 1 h, enone 21 (0.103 g, 0.50 mmol) in THF
(3 mL) was added via cannula. After stirring for 2 h, the reaction
was diluted with aq NaHCO3 and Et2O. The aq phase was extracted
with Et2O, the combined organic extracts dried (MgSO4), and the
solvent was removed in vacuo. To a solution of crude tertiary alco-
hol 22a in CH2Cl2 (10 mL) was added FeCl3 (82 mg, 0.50 mmol) at
r.t. After stirring at r.t. for 20 min, the reaction mixture was diluted
MS (EI): m/z (%) = 185 (67), 241 (34), 255 (8), 297 (92).
HRMS: m/z calcd for C20H27NO [M+]: 297.2093; found: 297.2083.
Acknowledgment
Acknowledgement is made to the National Institutes of Health
(GM57873) for generous support.
Synthesis 2004, No. 5, 786–790 © Thieme Stuttgart · New York